As of 2025-06-13, the Fair Value of InMed Pharmaceuticals Inc (IN.TO) is -15.55 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.19 CAD, the upside of InMed Pharmaceuticals Inc is -471.18%.
With the market price of 4.19 CAD and our fair value calculation, InMed Pharmaceuticals Inc (IN.TO) is not a good investment. Investing in IN.TO stocks now will result in a potential loss of 471.18%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| - | - | - | - | - | 5Y Avg | |
| Net income | - | - | - | - | - | - |
| YoY growth | - | - | - | - | - | -% |
| Market Cap (mil) | 33.73 |
| P/E | |
| Forward P/E |
| EPS | -2.27 |
| Avg earnings growth rate | -% |
| TTM earnings | -8.06 |